行业观察

FrontiersMay 7 2026 Embodying surgical robots with next-gen AI can safely augment practice if ethical and regulatory questions are addressed, say experts writing today in Frontiers in Science. A team

Helsingin yliopisto (University of Helsinki)May 7 2026 Nature-based group activities can reduce loneliness, improve sleep and cognition, and increase a sense of connection to nature in older adults li

Zhejiang UniversityMay 7 2026 Caustic ingestion remains a serious pediatric health problem, especially in domestic settings where corrosive substances may be improperly stored. While some children rec

By Tarun Sai LomteReviewed by Lauren HardakerMay 7 2026 Cranberry juice may help extend the lifespan of a key UTI antibiotic by reprogramming how bacteria absorb fosfomycin and evolve resistance. Stud

Chiba UniversityMay 7 2026 Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however,

By Dr. Sanchari Sinha Dutta, Ph.D.Reviewed by Lauren HardakerMay 7 2026 A next-generation AI model uncovers invisible signs of pancreatic cancer on standard CT scans long before symptoms appear, poten

Johns Hopkins UniversityMay 7 2026 Hospitals in Baltimore see an uptick in asthma-related emergency room cases in the weeks following nighttime heat waves in their neighboring communities, according t

Penn StateMay 7 2026 College students with anxiety, depression and eating disorders may be more likely to start and to respond more positively to therapy offered via a digital app compared to referral

The Permanente FederationMay 7 2026 A study published today in The Permanente Journal sheds light on what's driving physicians to leave clinical practice early - and how those reasons are shifting. Re

Rockefeller University PressMay 7 2026 As part of the body's first line of defense against foreign invaders, macrophages play an integral role in the innate immune system. However, the ability of macr

5月5日，据Fierce Biotech报道，辉瑞在最新公布的Q1财报中确认，已正式放弃收购自Trillium Therapeutics的最后一款处于临床阶段的候选药物——maplirpacept，这标志着辉瑞斥资23亿美元对Trillium Therapeutics的两款CD47抑制剂押注全部打水漂，此外，辉瑞还终止了多个项目的开发。23亿美元打水漂时间追溯到2021年8月，辉瑞宣布以22.6亿

2026年5月6日，时安生物（SiranBio）正式宣布与葛兰素史克（GSK）达成一项全球独家许可协议（中国大陆及港澳台地区除外），涉及核心资产SA030。SA030是一款极具潜力的同类首创（First-in-class）、长效siRNA寡核苷酸药物，近期已顺利进入I期临床试验阶段。该药物靶向激活素受体样激酶7（ALK7），这一靶点在心脏代谢疾病治疗领域已具备明确的机制基础。鉴于当前多种慢性疾病中

2026年5月6日，拜耳（Bayer）宣布与眼科生物制药公司Perfuse Therapeutics达成全资收购协议，通过此次收购，拜耳将获得Perfuse核心资产PER-001的全部权益，PER-001是一种目前处于临床Ⅱ期、用于青光眼和糖尿病视网膜病变（DR）的低分子内皮素受体拮抗剂。根据协议条款，这笔重磅交易的潜在总价值最高可达24.5亿美元，其中包括3亿美元的预付款，以及后续基于开发、监管

National Institutes of Health (NIH)May 6 2026 A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress eating for pleasure, or hedonic fe

University of BirminghamMay 6 2026 New research shows that the same genes are active in pancreatic cancer, obesity and diabetes, helping to explain why people with metabolic disease often face poorer